Regulation & law · 19/12/2003Updated: 10/17/2026 · 1 min read

National Institutes of Health to Grant Exclusive License for Zenapax as Multiple Sclerosis Treatment

Summary

The National Institutes of Health is considering granting an exclusive license to practice a novel treatment for multiple sclerosis, Zenapax, a humanized antibody against the IL-2 receptor alpha chain, developed by Protein Design Laboratories.

Original source language: Federal Register — All DocumentsOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Regulation & law · 10/13/2026

Notice of Intent To Grant Exclusive Patent License to Zyltech Engineering, LLC

The US Department of the Army intends to grant an exclusive patent license to Zyltech Engineering, LLC, a Houston-based company, located at 283 Lockhaven Drive, Suite 122, Houston, TX 77073.

Read summary →

Regulation & law · 10/13/2026

Changes in Mortgage and Loan Insurance Programs Under the National Housing Act

The Federal Housing Administration announces changes in interest rates for debentures issued under the National Housing Act, effective July 1, 2026, impacting loans and mortgages insured by the FHA.

Read summary →

Regulation & law · 10/13/2026

National Energy Dominance Month, 2026

The United States will observe National Energy Dominance Month in 2026 to recognize the country's energy production and consumption.

Read summary →

Regulation & law · 10/9/2026

US Judicial Conference Committee on Rules of Practice and Procedure to Hold In-Person Meeting

The Committee on Rules of Practice and Procedure of the US Judicial Conference will hold an in-person meeting on January 5, 2027, in Washington, DC, with virtual attendance options available, open to public observation.

Read summary →

Regulation & law · 10/8/2026

NSF Publishes Notice of Permit Applications Received Under the Antarctic Conservation Act of 1978

The U.S. National Science Foundation has published a notice of permit applications received for activities regulated under the Antarctic Conservation Act of 1978, as required by law.

Read summary →

Regulation & law · 10/8/2026

Oklahoma Advisory Committee to Hold Virtual Meetings

The Oklahoma Advisory Committee to the U.S. Commission on Civil Rights will hold virtual meetings via ZoomGov on multiple dates to plan upcoming panels on the death penalty.

Read summary →